BILL Holdings reports after the close on August 27 with analyst momentum at its firmest in months — a sharp contrast to the short-seller ambivalence that has defined positioning all summer.
The analyst story is the clearest signal heading into this print. Goldman Sachs and Morgan Stanley both lifted targets last week — Goldman to $57, Morgan Stanley to $60 — while Jefferies and UBS raised to $56 and $60 respectively. The consensus mean now sits at $56.90 against a $47.71 close, implying nearly 20% upside to the Street's central estimate. Wolfe Research added a further nudge on August 25, taking its target to $60 while holding Outperform. The direction of travel is unambiguous: even the more cautious voices — BMO and KBW both at Market Perform — raised targets by roughly $8-9 following what appears to have been a prior-quarter beat. That wave of upgrades is the backdrop against which tonight's print lands.
The short-selling picture has shifted since the August 19 release, though not dramatically. Short interest has edged up about 4.5% on the week to 10.2% of the float — a partial rebuild from the post-print low — but remains nearly 23% below the late-July peak above 13 million shares. Borrow conditions stay relaxed. Availability is running near 339%, meaning roughly three shares remain available to lend for every one currently borrowed, and cost to borrow at 0.50% is negligible. The ORTEX short score has crept to 60.9, its highest reading in the recent window, but that is a drift rather than a surge. Bears have not piled back in with conviction.
Options are mildly more defensive than the recent average. The put/call ratio is 0.45, about 0.77 standard deviations above its 20-day mean of 0.43 — modestly elevated but nowhere near the kind of skew that signals outright fear. The 52-week high on PCR is 0.93, so today's reading is well within a normal range. The stock is up 10% on the month but gave back about 3% on the week, leaving it at $47.71 after Tuesday's minor slip. Peers have been mixed: GWRE surged 11.6% on the week and VERX gained nearly 10%, while QTWO and AVPT traded flat. BILL's relative underperformance on the week, against a backdrop of rising analyst targets, adds a degree of tension to the setup.
The bull case centers on TAM expansion in SMB accounts payable and early traction from AI-driven spend management tools. Bears point to margin pressure from heavy stock-based compensation and execution risk in a competitive SMB software market. The forward EPS growth factor ranks in the 99th percentile of the universe — an extraordinary reading — but the eps_surprise factor sits at just the 15th percentile, a reminder that strong forward estimates have not always translated into beats on the day.
Tonight's print will test whether BILL can validate the analyst optimism that has outrun the stock over the past week, and whether a short base that stopped covering has reason to rebuild.
See the live data behind this article on ORTEX.
Open BILL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
